Blog

In response to the continuing state regulatory activity involving health plan and employer sponsored employee programs, we have attached a summary of these legislative updates. Feel free to contact your Fedeli Group service team to address your regulatory compliance questions and concerns. California Workers’ Compensation The California Workers’ Compensation Insurance Rating Bureau (WCIRB) released their September 1, […]

In today’s unpredictable insurance landscape, middle-market companies are rethinking how they manage risk. Traditional insurance models—where premiums are paid into a pooled system with little transparency or return—often fall short of aligning with a company’s financial goals or risk profile. Alternative Risk Solutions (ARS) offer a smarter, more strategic approach. These non-traditional insurance structures empower […]

With this bulletin we are providing updates designed to provide informative snapshot description alerts for topics at a state level, including: Not all the newly enacted regulations will result in the employer receiving a new direct obligation to address. Often, it is the health insurance carrier who is tasked with introducing a new requirement into […]

Employers that sponsor self-insured group health plans, including health reimbursement arrangements (HRAs) should keep in mind the upcoming July 31, 2025 deadline for paying fees that fund the Patient-Centered Outcomes Research Institute (PCORI) via Form 720, which was recently updated and released by the IRS.  As background, the PCORI was established as part of the […]

***Key takeaways following the enforcement pause of the 2024 Final Rule*** Group health plans and plan sponsors are no longer subject to the new compliance requirements scheduled to begin on 1/1/2025 and 1/1/2026.  On May 15, 2025, the U.S. Departments of Labor, Treasury, and Health and Human Services announced and released a Non-Enforcement Policy regarding […]

On April 15, 2025, President Trump commenced his administration’s agenda to lower drug costs by signing Executive Order EO 14273 titled, “Lowering Drug Prices By Once Again Putting Americans First”. To achieve EO 14273’s core focus to lower Medicare drug costs, specific agencies have been called upon to complete time-sensitive tasks. Here is a review […]